Omega Healthcare Investors Stock Price To Sales
| WX4 Stock | EUR 36.26 0.53 1.44% |
Omega Healthcare Investors fundamentals help investors to digest information that contributes to Omega Healthcare's financial success or failures. It also enables traders to predict the movement of Omega Stock. The fundamental analysis module provides a way to measure Omega Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Omega Healthcare stock.
Omega |
Omega Healthcare Investors Company Price To Sales Analysis
Omega Healthcare's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Omega Healthcare Price To Sales | 6.72 X |
Most of Omega Healthcare's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Omega Healthcare Investors is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Omega Healthcare Investors has a Price To Sales of 6.7204 times. This is 30.0% lower than that of the Real Estate sector and 12.72% lower than that of the REIT - Healthcare Facilities industry. The price to sales for all Germany stocks is 41.15% higher than that of the company.
Omega Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Omega Healthcare's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Omega Healthcare could also be used in its relative valuation, which is a method of valuing Omega Healthcare by comparing valuation metrics of similar companies.Omega Healthcare is rated third in price to sales category among its peers.
Omega Fundamentals
| Return On Equity | 0.11 | |||
| Return On Asset | 0.0258 | |||
| Profit Margin | 0.49 % | |||
| Operating Margin | 0.45 % | |||
| Current Valuation | 11.43 B | |||
| Shares Outstanding | 234.27 M | |||
| Shares Owned By Insiders | 0.39 % | |||
| Shares Owned By Institutions | 67.90 % | |||
| Price To Earning | 24.84 X | |||
| Price To Book | 1.85 X | |||
| Price To Sales | 6.72 X | |||
| Revenue | 878.24 M | |||
| Gross Profit | 794.08 M | |||
| EBITDA | 1 B | |||
| Net Income | 426.93 M | |||
| Cash And Equivalents | 40.03 M | |||
| Cash Per Share | 0.19 X | |||
| Total Debt | 5.27 B | |||
| Debt To Equity | 116.70 % | |||
| Current Ratio | 2.17 X | |||
| Book Value Per Share | 15.41 X | |||
| Cash Flow From Operations | 625.73 M | |||
| Earnings Per Share | 1.70 X | |||
| Target Price | 38.0 | |||
| Number Of Employees | 52 | |||
| Beta | 0.96 | |||
| Market Capitalization | 6.13 B | |||
| Total Asset | 9.41 B | |||
| Z Score | 0.6 | |||
| Annual Yield | 0.1 % | |||
| Five Year Return | 6.56 % | |||
| Net Asset | 9.41 B | |||
| Last Dividend Paid | 2.68 |
About Omega Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Omega Healthcare Investors's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Omega Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Omega Healthcare Investors based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Omega Stock
When determining whether Omega Healthcare Inv offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Omega Healthcare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Omega Healthcare Investors Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Omega Healthcare Investors Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Omega Healthcare Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.